Quan Venture Fund II, L.P. 4
4 · Design Therapeutics, Inc. · Filed Apr 1, 2021
Insider Transaction Report
Form 4
Quan Venture Fund II, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2021-03-30+280,991→ 4,720,830 total - Conversion
Common Stock
2021-03-30+4,439,839→ 4,439,839 total - Conversion
Series B Preferred Stock
2021-03-30−458,016→ 0 total→ Common Stock (280,991 underlying) - Conversion
Series A Preferred Stock
2021-03-30−7,236,938→ 0 total→ Common Stock (4,439,839 underlying)
Footnotes (1)
- [F1]All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.